Patents on novel device mechanisms, design on form factor, trademark on brand, regulatory filings that disclose IP — Indian medical devices live at the intersection of three regulatory regimes.
Indian medical devices is one of the fastest-growing manufacturing sectors in the country, driven by the National Medical Devices Policy 2023, the Production-Linked Incentive scheme, and the Make-in-India push for import substitution. The IP environment is dense. Patents on novel mechanisms, electronics and algorithms; design registrations on the physical form factor; trademarks on brand and device names; and a regulatory regime — Central Drugs Standard Control Organisation (CDSCO) under the Medical Devices Rules, 2017 — that requires technical disclosure as part of approval and creates patent-disclosure exposure if not managed carefully.
For Indian medical device startups, established manufacturers and contract development organisations, the IP file is also part of the regulatory file. Decisions made at the patent-filing stage affect what can be disclosed in CDSCO submissions; decisions made at the trademark-filing stage affect what brand names can be used on labels; decisions made on design registration affect the form factor's defensibility against copies.
Three filings cover most of the IP risk on day one. Each is a standalone service and each links to a deeper walkthrough.
Indian medical device patents face several distinct subject-matter exclusions:
Claim drafting workaround for Section 3(i): file device claims and combination claims rather than method claims. A claim to 'a device for [diagnosis/treatment] comprising [structural elements] configured to [operate as described]' is patentable; a claim to 'a method of diagnosing [condition]' is not.
The visual aesthetic of a medical device — handheld form factor, housing, control panel layout, display, port arrangement — is registrable under the Designs Act, 2000. Indian medical device designs are routinely filed in Class 24 (medical and laboratory instruments) of the Locarno classification. The design protects against close-imitation devices that copy the form factor but not the patented mechanism.
For Indian device companies, the design registration is often more accessible than the patent — faster, cheaper, with simpler examination. It protects the consumer-facing visible elements that drive customer recognition and aesthetic differentiation.
Indian medical device brand names operate in Class 10 (medical apparatus and instruments) plus Class 5 if the device contains a drug-delivery component, Class 9 for the electronics, and Class 35 for retail/dealer services. Defensive filings across these classes lock down the brand against confusingly similar entries in adjacent categories.
The label of a medical device must comply with the Medical Devices Rules, 2017 — including specifically named ingredients, batch numbers, expiry, certification logos. Trademark and label compliance interact: the brand name must be filed in advance because regulatory labels reference the registered name.
CDSCO submissions for device approval disclose technical detail — composition, mechanism, performance data. If these submissions are published or accessed by competitors before the corresponding patent is filed, they can become prior art that undermines the patent. The standard mitigation: file the patent application before filing the CDSCO submission, or at minimum file the provisional patent application before any public disclosure.
This is the single most common Indian medical-device IP failure pattern — regulatory submissions made too early, public conference presentations or trade-show demonstrations done before filing, and journal-article publications about clinical performance that disclose the inventive matter.
Counterfeit medical devices entering India through unauthorised channels are a real exposure for major brands. Customs recordation under the Intellectual Property Rights (Imported Goods) Enforcement Rules, 2007 allows interdiction at port. For Indian device manufacturers exporting branded products, similar recordation in destination markets — UAE, GCC, EU, ASEAN — is part of the international IP file.
Launching a medical device in India? File the patent before the CDSCO submission goes in. Send us the device spec — we'll map patent, design and trademark filings in one consult.
WhatsApp our team →Methods of medical treatment, surgery and diagnosis applied to the human body. The exclusion is method-specific, not device-specific. Device claims framed around the apparatus and its operational structure are patentable; procedural claims are not.
Class 10 (medical apparatus and instruments) is primary. Add Class 5 if the device contains drug-delivery components, Class 9 for electronic components, Class 35 for retail/dealer operations. A multi-class filing matches the multi-component nature of modern medical devices.
Yes if the submission discloses inventive subject matter publicly before the patent is filed. The standard practice is to file the patent (provisional or complete) before any regulatory submission, trade show demonstration or journal publication that discloses the invention.
Yes for the form factor — the visible housing, control layout and physical aesthetic. Design registration in Class 24 of the Locarno classification gives a separate enforcement route distinct from patents and trademarks, and is faster and cheaper to obtain than patents.